The Multifaceted Future of Pharma
We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries, including key disruptors and what can be improved… The key trends? AI, cell and gene therapies, and a need to reduce costs and improve patient access.
The Medicine Maker launched in September 2014 (Happy 10th Anniversary to us!). As part of celebration, we reached out to you – the medicine making community – to ask for your views on the last decade in pharma and healthcare, including key disruptors, and the big changes we can expect in next 10 years.
Overwhelmingly, well over 100 of you submitted your thoughts. And so, we decided to release The Medicine Maker’s Multifaceted Future of Pharma over the course of 11 exciting chapters. You can access a new chapter each month below.
The Multifaceted Future of Pharma – Chapter 1: The Big Picture
What will be the key disruptors and/or what can be improved upon in the pharma industry?
The Multifaceted Future of Pharma – Chapter 2: Pushing the Boundaries of Research & Drug Discovery
Here's how next-generation sequencing, protein-prediction tools, CRISPR, and more are yielding breakthroughs in drug discovery.
The Multifaceted Future of Pharma – Chapter 3: A World of AI, Data, and Automation
In Chapter 3, expert predictions turn to AI and machine learning, and how these technologies can bring added efficiency to the factory floor.
The Multifaceted Future of Pharma – Chapter 4: Therapeutic Areas to Watch
GLP-1s, mRNA, and Alzheimer’s are key areas to watch in the pharma world.
The Multifaceted Future of Pharma – Chapter 5: Betting on Biopharma and Better Bioprocessing
From sustainability to automation, here’s what the future of biopharma could look like, according to experts.
The Multifaceted Future of Pharma – Chapter 6: AI: Transforming Discovery and Development
From accelerated accuracy in the trials and approvals processes, to improved understanding of a disease at the molecular level, experts share their predictions.
The Multifaceted Future of Pharma – Chapter 7: Getting Smarter With Manufacturing
Read on for views on why sustainability, automation, AI, data and continuous processing will shape the future of manufacturing in the industry.
The Multifaceted Future of Pharma – Chapter 8: Clinical Development
How has the process of clinical development in the pharma industry improved over the past decade? Experts discuss and look at what the future holds for the field.